Results 11 to 20 of about 1,301,949 (212)

Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force [PDF]

Value in Health, 2014
Budget impact analyses (BIAs) are an essential part of a comprehensive economic assessment of a health care intervention and are increasingly required by reimbursement authorities as part of a listing or reimbursement submission.The objective of this report was to present updated guidance on methods for those undertaking such analyses or for those ...
Sullivan, Sean D., Mauskopf, Josephine A., Augustovski, Federico, Jaime Caro, J., Lee, Karen M., Minchin, Mark, Orlewska, Ewa, Penna, Pete, Rodriguez Barrios, Jose-Manuel, Shau, Wen-Yi   +9 more
openaire   +4 more sources

Cost-Minimization Analysis and Budget Impact Analysis About Subcutaneous Natalizumab in Relapsing-Remitting Multiple Sclerosis in Italy [PDF]

ClinicoEconomics and Outcomes Research
Luca Prosperini,1 Lorenzo Pradelli,2 Laura Santoni,3 Daria Perini,3 Salvatore Cottone,4 Marco Vercellino5 1S. Camillo-Forlanini Hospital, Rome, Italy; 2AdRes Health Economics and Outcomes Resources, Turin, Italy; 3Biogen Italia, Milan, Italy; 4Department
Prosperini L, Pradelli L, Santoni L, Perini D, Cottone S, Vercellino M   +5 more
doaj   +2 more sources

Adding Tolvaptan in the Inpatient Treatment for Patients with Heart Failure and Hyponatremia: Budget Impact Analysis in Thailand [PDF]

ClinicoEconomics and Outcomes Research
Unchalee Permsuwan,1,2 Krit Leemasawat,3 Poukwan Arunmanakul1,2,4 1Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand; 2Center for Medical and Health Technology Assessment (CM-HTA), Department of ...
Permsuwan U, Leemasawat K, Arunmanakul P
doaj   +2 more sources

Budget impact analysis of baricitinib for treatment of alopecia areata: A Saudi hospital perspective [PDF]

Saudi Pharmaceutical Journal
Objectives: To perform a budget impact analysis (BIA) of the adoption of baricitinib for the management of alopecia areata (AA) by a Saudi public sector payer.
A. Alshahrani, S. Al-Aqeel, M. Alshahrani, S. Alqahtani, S.T. Alhawwashi, M.S. Al-Nasser, M. Zaitoun   +6 more
doaj   +2 more sources

Transversal Budget Impact Analysis

, 2023
109 p. ill., 1 INTRODUCTION 11 -- 1.1 CONTEXT 11 -- 1.2 AIM OF THE STUDY 13 -- 1.2.1 Research questions .13 -- 1.3 METHODS 14 -- 1.3.1 Two case studies 14 -- 1.3.2 Data sources analyzed 14 -- 1.3.3 Methods for the data analysis .15 -- 1.4 REPORT OUTLINE .17 -- 2 BACKGROUND 17 -- 2.1 THE GLOBAL AND PARTIAL BUDGETS OF THE FEDERAL RIZIV-INAMI ...
Camberlin, Cécile, Obyn, Caroline, Neyt, Mattias   +2 more
openaire   +3 more sources

Good practices for the development of budget impact models at regional level

Global & Regional Health Technology Assessment, 2023
Introduction: The present work aims to discuss the current scenario of procedures and regulations regarding budget impact analysis/models (BIA/BIM) at regional level in Italy and to provide a standardized approach and detailed recommendations for ...
Andrea Marcellusi, Angela Ragonese, Andrea Marinozzi, Alberto Bortolami, Sara Mucherino, Carolina Moreno, Amalia Antenori, Matteo Ferrario, Claudia Simonelli, Matteo Zanussi, Marco Cicoira, Ruggero Lasala, Francesco Russoniello, Francesco Attanasio, Caterina Donati, Chiara Roni, Fabrizio Gemmi, Francesco Saverio Mennini, Pierluigi Russo, Giovanna Scroccaro, PierLuigi Canonico   +20 more
doaj   +1 more source

Budget impact analysis of extended half-life recombinant factor IX (rFIXFc) in the treatment of haemophilia B

Global & Regional Health Technology Assessment, 2020
Introduction: Prophylaxis with factor IX (FIX) concentrates, produced by recombinant DNA technology (rFIX) or human plasma-derived concentrates, is the treatment of choice for haemophilia B (HB); rFIX covalently fused to the Fc domain of human ...
Andrea Aiello, Maria Elisa Mancuso, Alessio Colombo, Cristina Teruzzi, Patrizia Berto   +4 more
doaj   +1 more source

Health Plan Budget Impact Analysis for Pimecrolimus [PDF]

Journal of Managed Care Pharmacy, 2005
Budget impact models are useful tools for managed care organizations to make drug formulary decisions. The objective of this study was to estimate the incremental budgetary change in per-member-per-month (PMPM) medical and pharmacy costs for atopic dermatitis (AD) or eczema after the introduction of pimecrolimus cream 1%, a topical calcineurin ...
Jane, Chang, Jennifer, Sung
openaire   +2 more sources

Budget impact analysis of a pilot polypharmacy clinic

British Journal of Healthcare Management, 2022
Background/Aims Inappropriate polypharmacy can lead to adverse events and increased healthcare costs. This study estimated the budget impact of providing a specialist onward referral service for patients with potentially problematic polypharmacy. Methods A multidisciplinary team-led pilot polypharmacy clinic, dedicated to reviewing patients prescribed ...
Bennett, Frances, Barron, Andrew, Shah, Neha, Webb, David J, Sofat, Reecha   +4 more
openaire   +2 more sources

Budget impact analysis of surfactant therapy for bronchiolitis in critically ill infants: the Colombian National Health System perspective

BMC Health Services Research, 2021
Background Severe bronchiolitis requiring mechanical ventilation was associated with an absence of surfactant activity and phosphatidylglycerol, causing airway obstruction in acute bronchiolitis.
Jefferson Antonio Buendía, Diana Guerrero Patiño   +1 more
doaj   +1 more source